Neuroendocrine Cancer | Tumor

Inlyta-Synthetic Hormone Combo Fails to Significantly Improve Survival Outcome in Pancreatic Neuroendocrine Tumors

January 20th 2021, 2:00pm


The combination of Inlyta (axitinib) and the synthetic hormone octreotide acetate failed to significantly improve progression-free survival, compared to placebo with the synthetic hormone. However, the results indicated the Inlyta-based combination did improve disease response in patients versus the placebo-based combination.

Appendix Cancer: An Elusive Diagnosis

August 26th 2020, 6:00pm


Often uncovered by accident, appendiceal cancers trigger few symptoms until they’re advanced and can be difficult to detect and treat.

Cancer Survivors Are Equipped to Handle Quarantine

April 14th 2020, 10:21pm


COVID-19 has forced many people into a “new normal” that they aren’t familiar with and may not be equipped to handle. But cancer survivors are more prepared than most to handle the ramifications of the pandemic.

Patients With High-Grade Neuroendocrine Tumors Show Response After Opdivo/Yervoy Treatment

September 27th 2019, 12:00am


Treatment with Opdivo (nivolumab) plus Yervoy (ipilimumab) led to a 44% response rate in patients with high-grade neuroendocrine tumors, according to phase 2 study findings.

Friday Frontline: Cancer Updates, Research and Education on August 23, 2019

August 23rd 2019, 6:00pm


From celebrity news to a new partnership aimed to help patients and their caregivers, here’s what is making headlines in the cancer space this week.

Dedicated to Oncology

June 15th 2019, 4:00pm


This essay was written by Tracey M. Hopkins nominating registered nurse Rubirosa Ison, St. Joseph’s Hospital-North, Lutz, Florida, for CURE®’s 2019 Extraordinary Healer® Award.

Poker Face or Cancer Card?

October 12th 2017, 7:03am


Before I was diagnosed, I had my share of illnesses, but none that slowed me down like cancer could.

Cancer Isn't All About Me

October 4th 2017, 5:58am


Since my diagnosis of incurable and metastatic neuroendocrine cancer in 2010, it's really all been about me.